Financials
Financial year 2025
Nuscience Belgium from Gent, company number BE0412718370, closed financial year 2025 with a result of € 7.6 million after tax. For that financial year Nuscience Belgium recorded revenue of € 173.8 million and equity of € 113.2 million. Compared with financial year 2024, the result moved from € 6.2 million to € 7.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
€ 113.2 million
▲ 75% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 7.6 million
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 4.5 million
▲ 88% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 12.2 million.
People and assets in 2025
127.2
▲ 25.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 13 million
▲ 53% vs 2024
€ 102,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 261,852
▼ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 25 million
▲ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 59 days on average.
€ 3.7 million
▲ 36% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 176,772,106 | € 168,632,865 | € 166,061,748 | € 173,808,252 | ▲ 5% |
| Profit after taxes | € 2,103,784 | € 540,026 | € 6,236,067 | € 7,601,402 | ▲ 22% |
| Equity | € 57,789,624 | € 58,329,650 | € 64,565,717 | € 113,181,825 | ▲ 75% |
| Total debts | € 31,232,012 | € 28,149,194 | € 24,305,296 | € 28,719,099 | ▲ 18% |
| Cash | € 6,952,625 | € 2,883,240 | € 2,411,165 | € 4,531,682 | ▲ 88% |
| Land & buildings | € 17,154,641 | € 16,743,565 | € 16,306,681 | € 16,110,559 | ▼ 1% |
| Retained profit | € 16,177,862 | € 16,717,889 | € 22,953,956 | € 12,158,511 | ▼ 47% |
| Balance sheet total | € 89,023,124 | € 86,480,332 | € 90,117,501 | € 144,802,411 | ▲ 61% |
| Employees (FTE) | 107 | 100.2 | 101.9 | 127.2 | ▲ 25.3 |
Key figures of Nuscience Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Nuscience Belgium?
What happened at Nuscience Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bastiaan Van Driel stepped down as director. NBB
- Philippe van Troost stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 7.6 million (▲ 22% vs 2024). Source: NBB ↗
- Bastiaan Van Driel became a director. NBB
- Jolanda Van Haarlem stepped down as director. NBB
- Jolanda Van Haarlem became a director. NBB
- Philippe van Troost became a director. NBB
- New establishment in Gent. KBO
In short
From € 2.1 million profit in 2022 to € 7.6 million profit in 2025.
Paid € 5.4 million in corporate taxes since 2022.
Best year ever: 2025, with € 7.6 million profit.
Pays suppliers within 59 days on average.
Management
The stake of Nuscience Group comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Nuscience BelgiumThe shares are held by Agrifirm International B.V. (100%) and Nuscience Group (100%). It owns 100% of Nuscience Iberica S.a.u., 100% of Nutrition Sciences, 100% of Nuscience Italia SRL, 100% of Vitamex Shanghai, 100% of Nuscience Premix international d.o.o. and 100% of Lusai NV itself.
Directors
According to the 2025 annual accounts
since 2025 · until 2031
Jolanda Van Haarlem
Director
since 2025 · until 2025
Philippe van Troost
Director
since 2023 · until 2029
Shareholders
Agrifirm International B.V.
100%
100%
Participations
Nuscience Iberica S.a.u.
100%
100%
Nuscience Italia SRL
100%
Vitamex Shanghai
100%
Nuscience Premix international d.o.o.
100%
100%
100%
Agrifirm do Brasil Nutricao Animal Ltda
100%
Nuscience Singapore
100%
LLC Cehave Korm Ltd
50%
Establishments
Establishment units
Physical locations of this company
Booiebos 5
9031 Gent
Industriepark-Drongen 3 box 2
9031 Gent
Active since 1 April 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Barracuda
Hosting
MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US
Domain
Domain
nusciencegroup.com
Registered
2011-05-10
Registrar
Hosting Concepts B.V. d/b/a Registrar.eu
Expires
2026-05-10
Website info
Features
Security
Details
- Company number
- 0412.718.370
- VAT number
- BE 0412.718.370
- Registered office
- Booiebos 5, 9031 Gent
- Names & denominations
- Nuscience Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 October 1972
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van veevoeders